Examination of Foot Posture's Change on Balance in Different Disorders

Sponsor
Istanbul Medipol University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05909345
Collaborator
(none)
150
1
4.9
30.8

Study Details

Study Description

Brief Summary

Foot; It is a terminal joint that opposes external resistance in the lower kinetic chain. It plays a primary role in weight transfer and ground response between the body and the ground.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To investigate the extent to which foot posture affects balance and foot function in different disease groups. The amount of studies examining the effect of the postural structure of the foot and balance seen in different disease groups in the literature is insufficient.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Examination of Foot Posture's Change on Balance in Different Disorders
    Anticipated Study Start Date :
    Jun 15, 2023
    Anticipated Primary Completion Date :
    Jun 15, 2023
    Anticipated Study Completion Date :
    Nov 10, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Knee Osteoarthritis

    Nonspecific Low Back Pain

    Outcome Measures

    Primary Outcome Measures

    1. Navicular Drop Test [one day]

      The distance between the tubercle of the navicular, which is the attachment of the tibialis posterior muscle, and the ground, was measured in this position by asking each participant to give full weight to their bare feet. The distance between the navicular tubercle and the ground was measured without any weight on the feet in the subtalar neutral position. The difference between this distance and the amount of navicular height was recorded as navicular drop (millimetres).

    2. Foot Posture Index [one day]

      Foot Posture consists of palpation of 6 regions. Each criterion is evaluated between -2 and +2 and this result is noted. Positive values indicate pronation, negative values indicate supination.

    3. Y Balance Test [one day]

      The leg lengths of all individuals are measured bilaterally. While measuring, individuals are asked to lie in their anterior, posteromedial and posterolateral directions. Each of the participants is informed before the measurement. Measurements were made in both legs and will be repeated 3 times. When calculating the total score, the values in centimeters of the 3 directions are added. Divide by the product of the length of the leg by 3 and multiply the result by 100 to reach the percentile.

    Secondary Outcome Measures

    1. Oswestry Low Back Pain Disability Questionnaire [one day]

      It includes 1 item about pain and 9 items about activities of daily living. Each item is measured on a 6-point rank scale between 0 and 5 points according to the scenarios it contains. At the end of the survey, scores are summed up and a high score means loss of disability.

    2. Western Ontario and MacMaster (WOMAC) [one day]

      Western Ontario and MacMaster (WOMAC) is evaluated by dividing it into three groups as pain, stiffness and physical function, consisting of a total of 24 questions used in the evaluation of lower extremity OA. The total WOMAC score is obtained by summing up all the values by evaluating these three titles separately. At the end of the questionnaire, scores are summed up and a high score means loss of disability.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion criteria;

    • Being between the ages of 45 - 65,

    • Volunteer. Exclusion criteria;

    • Having a musculoskeletal or neuromuscular disease that limits mobility,

    • Presence of lower extremity sequelae,

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Medipol hospital Istanbul Istanbul Avrupa Kitasi Turkey 34353

    Sponsors and Collaborators

    • Istanbul Medipol University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    hazal genc, Principal Investigator, Istanbul Medipol University Hospital
    ClinicalTrials.gov Identifier:
    NCT05909345
    Other Study ID Numbers:
    • E-85646034-604.02.02-60261
    First Posted:
    Jun 18, 2023
    Last Update Posted:
    Jun 18, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by hazal genc, Principal Investigator, Istanbul Medipol University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 18, 2023